COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Monthly Archives:
August 2014

14

August
2014

category:

503b Compounding

Shortage of epilepsy drugs in Zimbabwe

HARARE, 11 August 2014 (IRIN) – Drugs for non-communicable diseases like epilepsy are being hardest hit by funding shortfalls affecting Zimbabwe’s publichealth sector. While the government is struggling to meet its budget commitments, donors are more focused on communicable diseases like HIV and TB.Tsarai Moto*, 25, from Musami village in Mashonaland East Province about 80km […]

read more

14

August
2014

category:

503b Compounding

Belgian pharma trade body issues recommendations on domestic drug shortages

Belgium’s pharmaceutical trade body, pharma.be, has issued a conclusion of its report on the shortage and unavailability of drugs in the Belgian market. While acknowledging that manufacturing standards often mean temporary production and supply issues, pharma.be has highlighted the free circulation of goods within the European Union as a source of drug shortages in Belgium […]

read more

6

August
2014

category:

503b Compounding

Enforcement Updates – Pharmaceutical & Medical Device Regulatory Update, Issue 11

Recent Product Recalls FDA announced two voluntary, company-initiated recalls. The first recall was from a compounding pharmacy recalling all nonexpired sterile drug preparations due to FDA’s concerns about the lack of sterility associated with the company’s compounding processes. The second recall, initiated by a medical packaging company, involved a recall of certain hospital dose units […]

read more